A 10-year retrospective cohort study of ruxolitinib and association with nonmelanoma skin cancer in patients with polycythemia vera and myelofibrosis
John Q. Lin, Shirley Q. Li, Shufeng Li, Eileen F. Kiamanesh, Sumaira Z. Aasi, Bernice Y. Kwong, Anne Lynn S. Chang
Topics & Concepts
RuxolitinibMedicineMyelofibrosisSkin cancerHazard ratioRetrospective cohort studyInternal medicineCohortPolycythemia veraJanus kinase inhibitorCancerBasal cell carcinomaOncologySurgeryConfidence intervalTofacitinibBasal cellBone marrowRheumatoid arthritisMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research